Erratum: Alzheimer's Disease-Associated β-Amyloid Is Rapidly Seeded by Herpesviridae to Protect against Brain Infection (Neuron (2018) 99(1) (56–63.e3), (S0896627318305269), (10.1016/j.neuron.2018.06.030));Alzheimer's Disease-Associated β-Amyloid Is Rapidly Seeded by Herpesviridae to Protect against Brain Infection

Neuron

Volumn 99, Issue 1, 2018, Pages 56-63.e3

  Eimer, William A ^a   Vijaya Kumar, Deepak Kumar ^a   Navalpur Shanmugam, Nanda Kumar ^a   Rodriguez, Alex S ^a   Mitchell, Teryn ^a   Washicosky, Kevin J ^a   György, Bence ^a   Breakefield, Xandra O ^a   Tanzi, Rudolph E ^a   Moir, Robert D ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Alzheimer's disease; amyloid ; antimicrobial peptide; herpes simplex virus 1; herpesviridae; herpesvirus glycoprotein; human herpesvirus 6; infection; oligomers; amyloid peptide

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; AMYLOID PRECURSOR PROTEIN; BETA SECRETASE; CD134 ANTIGEN; MEMBRANE COFACTOR PROTEIN; OLIGOMER;

ALZHEIMER DISEASE; AMYLOIDOSIS; ANIMAL CELL; ANIMAL MODEL; ANTIMICROBIAL ACTIVITY; ANTIVIRAL ACTIVITY; ARTICLE; BRAIN CELL CULTURE; BRAIN INFECTION; CONTROLLED STUDY; DISEASE EXACERBATION; ENCEPHALITIS; H4 CELL LINE; HERPES VIRUS INFECTION; HERPESVIRIDAE; HOST CELL; HUMAN; HUMAN ALPHAHERPESVIRUS 1; HUMAN CELL; IMMUNOMODULATION; INNATE IMMUNITY; MOUSE; NEUROFIBRILLARY TANGLE; NONHUMAN; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; SEQUENCE HOMOLOGY; VIRUS INFECTIVITY; VIRUS PARTICLE;

EID: 85049298591     PISSN: 08966273     EISSN: 10974199     Source Type: Journal    
DOI: 10.1016/j.neuron.2018.11.043     Document Type: Erratum

References (59)

1. Alonso, R., Pisa, D., Marina, A.I., Morato, E., Rábano, A., Carrasco, L., Fungal infection in patients with Alzheimer's disease. J. Alzheimers Dis. 41 (2014), 301–311.
2. Araki-Sasaki, K., Ando, Y., Nakamura, M., Kitagawa, K., Ikemizu, S., Kawaji, T., Yamashita, T., Ueda, M., Hirano, K., Yamada, M., et al. Lactoferrin Glu561Asp facilitates secondary amyloidosis in the cornea. Br. J. Ophthalmol. 89 (2005), 684–688.
3. Arnusch, C.J., Branderhorst, H., de Kruijff, B., Liskamp, R.M.J., Breukink, E., Pieters, R.J., Enhanced membrane pore formation by multimeric/oligomeric antimicrobial peptides. Biochemistry 46 (2007), 13437–13442.
4. Bourgade, K., Garneau, H., Giroux, G., Le Page, A.Y., Bocti, C., Dupuis, G., Frost, E.H., Fülöp, T. Jr., β-Amyloid peptides display protective activity against the human Alzheimer's disease-associated herpes simplex virus-1. Biogerontology 16 (2015), 85–98.
5. Bourgade, K., Le Page, A., Bocti, C., Witkowski, J.M., Dupuis, G., Frost, E.H., Fülöp, T. Jr., Protective effect of amyloid-β peptides against herpes simplex virus-1 infection in a neuronal cell culture model. J. Alzheimers Dis. 50 (2016), 1227–1241.
6. Campadelli-Fiume, G., Mirandola, P., Menotti, L., Human herpesvirus 6: an emerging pathogen. Emerg. Infect. Dis. 5 (1999), 353–366.
7. Carter, C.J., Interactions between the products of the Herpes simplex genome and Alzheimer's disease susceptibility genes: relevance to pathological-signalling cascades. Neurochem. Int. 52 (2008), 920–934.
8. Castillo, G.M., Cummings, J.A., Yang, W., Judge, M.E., Sheardown, M.J., Rimvall, K., Hansen, J.B., Snow, A.D., Sulfate content and specific glycosaminoglycan backbone of perlecan are critical for perlecan's enhancement of islet amyloid polypeptide (amylin) fibril formation. Diabetes 47 (1998), 612–620.
9. Choi, S.H., Kim, Y.H., Hebisch, M., Sliwinski, C., Lee, S., D'Avanzo, C., Chen, H., Hooli, B., Asselin, C., Muffat, J., et al. A three-dimensional human neural cell culture model of Alzheimer's disease. Nature 515 (2014), 274–278.
10. Chu, H., Pazgier, M., Jung, G., Nuccio, S.-P., Castillo, P.A., de Jong, M.F., Winter, M.G., Winter, S.E., Wehkamp, J., Shen, B., et al. Human α-defensin 6 promotes mucosal innate immunity through self-assembled peptide nanonets. Science 337 (2012), 477–481.
11. Ciornei, C.D., Tapper, H., Bjartell, A., Sternby, N.H., Bodelsson, M., Human antimicrobial peptide LL-37 is present in atherosclerotic plaques and induces death of vascular smooth muscle cells: a laboratory study. BMC Cardiovasc. Disord., 6, 2006, 49.
12. Fischer, M.H., The physiology of glycosuria. Calif. State J. Med. 5 (1907), 229–231.
13. Griciuc, A., Serrano-Pozo, A., Parrado, A.R., Lesinski, A.N., Asselin, C.N., Mullin, K., Hooli, B., Choi, S.H., Hyman, B.T., Tanzi, R.E., Alzheimer's disease risk gene CD33 inhibits microglial uptake of amyloid β. Neuron 78 (2013), 631–643.
14. Hahn, S., Brüning, T., Ness, J., Czirr, E., Baches, S., Gijsen, H., Korth, C., Pietrzik, C.U., Bulic, B., Weggen, S., Presenilin-1 but not amyloid precursor protein mutations present in mouse models of Alzheimer's disease attenuate the response of cultured cells to γ-secretase modulators regardless of their potency and structure. J. Neurochem. 116 (2011), 385–395.
15. Harris, S.A., Harris, E.A., Herpes simplex virus type 1 and other pathogens are key causative factors in sporadic Alzheimer's disease. J. Alzheimers Dis. 48 (2015), 319–353.
16. Hazrati, E., Galen, B., Lu, W., Wang, W., Ouyang, Y., Keller, M.J., Lehrer, R.I., Herold, B.C., Human alpha- and β-defensins block multiple steps in herpes simplex virus infection. J. Immunol. 177 (2006), 8658–8666.
17. Heneka, M.T., Golenbock, D.T., Latz, E., Innate immunity in Alzheimer's disease. Nat. Immunol. 16 (2015), 229–236.
18. Hill, J.A., Venna, N., Human herpesvirus 6 and the nervous system. Handb. Clin. Neurol. 123 (2014), 327–355.
19. Hoover, D.M., Rajashankar, K.R., Blumenthal, R., Puri, A., Oppenheim, J.J., Chertov, O., Lubkowski, J., The structure of human β-defensin-2 shows evidence of higher order oligomerization. J. Biol. Chem. 275 (2000), 32911–32918.
20. Itzhaki, R.F., Herpes simplex virus type 1 and Alzheimer's disease: increasing evidence for a major role of the virus. Front. Aging Neurosci., 6, 2014, 202.
21. Itzhaki, R.F., Lin, W.R., Shang, D., Wilcock, G.K., Faragher, B., Jamieson, G.A., Herpes simplex virus type 1 in brain and risk of Alzheimer's disease. Lancet 349 (1997), 241–244.
22. Itzhaki, R.F., Lathe, R., Balin, B.J., Ball, M.J., Bearer, E.L., Braak, H., Bullido, M.J., Carter, C., Clerici, M., Cosby, S.L., et al. Microbes and Alzheimer's disease. J. Alzheimers Dis. 51 (2016), 979–984.
23. Jamieson, G.A., Maitland, N.J., Wilcock, G.K., Craske, J., Itzhaki, R.F., Latent herpes simplex virus type 1 in normal and Alzheimer's disease brains. J. Med. Virol. 33 (1991), 224–227.
24. Kee, K.H., Lee, M.J., Shen, S.S., Suh, J.H., Lee, O.-J., Cho, H.Y., Ayala, A.G., Ro, J.Y., Amyloidosis of seminal vesicles and ejaculatory ducts: a histologic analysis of 21 cases among 447 prostatectomy specimens. Ann. Diagn. Pathol. 12 (2008), 235–238.
25. Kumar, D.K., Choi, S.H., Washicosky, K.J., Eimer, W.A., Tucker, S., Ghofrani, J., Lefkowitz, A., McColl, G., Goldstein, L.E., Tanzi, R.E., Moir, R.D., Amyloid-β peptide protects against microbial infection in mouse and worm models of Alzheimer's disease. Sci. Transl. Med., 8, 2016, 340ra72.
26. Lewis, P.A., Piper, S., Baker, M., Onstead, L., Murphy, M.P., Hardy, J., Wang, R., McGowan, E., Golde, T.E., Expression of BRI-amyloid β peptide fusion proteins: a novel method for specific high-level expression of amyloid β peptides. Biochim. Biophys. Acta 1537 (2001), 58–62.
27. Linke, R.P., Joswig, R., Murphy, C.L., Wang, S., Zhou, H., Gross, U., Rocken, C., Westermark, P., Weiss, D.T., Solomon, A., Senile seminal vesicle amyloid is derived from semenogelin I. J. Lab. Clin. Med. 145 (2005), 187–193.
28. Luna, S., Cameron, D.J., Ethell, D.W., Amyloid-β and APP deficiencies cause severe cerebrovascular defects: important work for an old villain. PLoS ONE, 8, 2013, e75052.
29. Lusso, P., Human herpesvirus 6 (HHV-6). Antiviral Res. 31 (1996), 1–21.
30. Mawanda, F., Wallace, R., Can infections cause Alzheimer's disease?. Epidemiol. Rev. 35 (2013), 161–180.
31. McGeoch, D.J., Gatherer, D., Integrating reptilian herpesviruses into the family herpesviridae. J. Virol. 79 (2005), 725–731.
32. Millucci, L., Paccagnini, E., Ghezzi, L., Bernardini, G., Braconi, D., Laschi, M., Consumi, M., Spreafico, A., Tanganelli, P., Lupetti, P., et al. Different factors affecting human ANP amyloid aggregation and their implications in congestive heart failure. PLoS ONE, 6, 2011, e21870.
33. Oakley, H., Cole, S.L., Logan, S., Maus, E., Shao, P., Craft, J., Guillozet-Bongaarts, A., Ohno, M., Disterhoft, J., Van Eldik, L., et al. Intraneuronal β-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: potential factors in amyloid plaque formation. J. Neurosci. 26 (2006), 10129–10140.
34. Oren, Z., Lerman, J.C., Gudmundsson, G.H., Agerberth, B., Shai, Y., Structure and organization of the human antimicrobial peptide LL-37 in phospholipid membranes: relevance to the molecular basis for its non-cell-selective activity. Biochem. J. 341 (1999), 501–513.
35. Pachón-Ibáñez, M.E., Smani, Y., Pachón, J., Sánchez-Céspedes, J., Perspectives for clinical use of engineered human host defense antimicrobial peptides. FEMS Microbiol. Rev. 41 (2017), 323–342.
36. Pálffy, R., Gardlík, R., Behuliak, M., Kadasi, L., Turna, J., Celec, P., On the physiology and pathophysiology of antimicrobial peptides. Mol. Med. 15 (2009), 51–59.
37. Paulsen, F., Pufe, T., Conradi, L., Varoga, D., Tsokos, M., Papendieck, J., Petersen, W., Antimicrobial peptides are expressed and produced in healthy and inflamed human synovial membranes. J. Pathol. 198 (2002), 369–377.
38. Pereira, H.A., Kumar, P., Grammas, P., Expression of CAP37, a novel inflammatory mediator, in Alzheimer's disease. Neurobiol. Aging 17 (1996), 753–759.
39. Perez-Nievas, B.G., Stein, T.D., Tai, H.C., Dols-Icardo, O., Scotton, T.C., Barroeta-Espar, I., Fernandez-Carballo, L., de Munain, E.L., Perez, J., Marquie, M., et al. Dissecting phenotypic traits linked to human resilience to Alzheimer's pathology. Brain 136 (2013), 2510–2526.
40. Pisa, D., Alonso, R., Rábano, A., Rodal, I., Carrasco, L., Different brain regions are infected with fungi in Alzheimer's disease. Sci. Rep., 5, 2015, 15015.
41. Readhead, B., Haure-Mirande, J.-V., Funk, C.C., Richards, M.A., Shannon, P., Haroutunian, V., Sano, M., Liang, W.S., Beckmann, N.D., Price, N.D., et al. Multiscale analysis of independent Alzheimer's cohorts finds disruption of molecular, genetic, and clinical networks by human herpesvirus. Neuron 99 (2018), 64–82 this issue.
42. Reinholz, M., Ruzicka, T., Schauber, J., Cathelicidin LL-37: an antimicrobial peptide with a role in inflammatory skin disease. Ann. Dermatol. 24 (2012), 126–135.
43. Scarpa, M., Grillo, A., Scarpa, M., Brun, P., Castoro, C., Pozza, A., Cavallo, D., Faggian, D., Ruffolo, C., D'Incà R., et al. Innate immune environment in ileal pouch mucosa: α5 defensin up-regulation as predictor of chronic/relapsing pouchitis. J. Gastrointest. Surg. 16 (2012), 188–201 discussion 201–202.
44. Sood, R., Domanov, Y., Pietiäinen, M., Kontinen, V.P., Kinnunen, P.K.J., Binding of LL-37 to model biomembranes: insight into target vs host cell recognition. Biochim. Biophys. Acta 1778 (2008), 983–996.
45. Soscia, S.J., Kirby, J.E., Washicosky, K.J., Tucker, S.M., Ingelsson, M., Hyman, B., Burton, M.A., Goldstein, L.E., Duong, S., Tanzi, R.E., Moir, R.D., The Alzheimer's disease-associated amyloid β-protein is an antimicrobial peptide. PLoS ONE, 5, 2010, e9505.
46. Torrent, M., Pulido, D., Nogués, M.V., Boix, E., Exploring new biological functions of amyloids: bacteria cell agglutination mediated by host protein aggregation. PLoS Pathog., 8, 2012, e1003005.
47. Tsai, P.-W., Yang, C.-Y., Chang, H.-T., Lan, C.-Y., Characterizing the role of cell-wall β-1,3-exoglucanase Xog1p in Candida albicans adhesion by the human antimicrobial peptide LL-37. PLoS ONE, 6, 2011, e21394.
48. Tsai, P.-W., Yang, C.-Y., Chang, H.-T., Lan, C.-Y., Human antimicrobial peptide LL-37 inhibits adhesion of Candida albicans by interacting with yeast cell-wall carbohydrates. PLoS ONE, 6, 2011, e17755.
49. Tzeng, N.S., Chung, C.H., Lin, F.H., Chiang, C.P., Yeh, C.B., Huang, S.Y., Lu, R.B., Chang, H.A., Kao, Y.C., Yeh, H.W., et al. Anti-herpetic medications and reduced risk of dementia in patients with herpes simplex virus infections-a nationwide, population-based cohort study in Taiwan. Neurotherapeutics 15 (2018), 417–429.
50. van Horssen, J., Wesseling, P., van den Heuvel, L.P.W.J., de Waal, R.M.W., Verbeek, M.M., Heparan sulphate proteoglycans in Alzheimer's disease and amyloid-related disorders. Lancet Neurol. 2 (2003), 482–492.
51. Wang, J., Li, Y., Wang, X., Chen, W., Sun, H., Wang, J., Lipopolysaccharide induces amyloid formation of antimicrobial peptide HAL-2. Biochim. Biophys. Acta 1838 (2014), 2910–2918.
52. Watson, D.J., Lander, A.D., Selkoe, D.J., Heparin-binding properties of the amyloidogenic peptides Abeta and amylin. Dependence on aggregation state and inhibition by Congo red. J. Biol. Chem. 272 (1997), 31617–31624.
53. White, M.R., Kandel, R., Tripathi, S., Condon, D., Qi, L., Taubenberger, J., Hartshorn, K.L., Alzheimer's associated β-amyloid protein inhibits influenza A virus and modulates viral interactions with phagocytes. PLoS ONE, 9, 2014, e101364.
54. Wozniak, M.A., Itzhaki, R.F., Shipley, S.J., Dobson, C.B., Herpes simplex virus infection causes cellular β-amyloid accumulation and secretase upregulation. Neurosci. Lett. 429 (2007), 95–100.
55. Wozniak, M.A., Mee, A.P., Itzhaki, R.F., Herpes simplex virus type 1 DNA is located within Alzheimer's disease amyloid plaques. J. Pathol. 217 (2009), 131–138.
56. Xhindoli, D., Pacor, S., Guida, F., Antcheva, N., Tossi, A., Native oligomerization determines the mode of action and biological activities of human cathelicidin LL-37. Biochem. J. 457 (2014), 263–275.
57. Yamaguchi, Y., Nagase, T., Tomita, T., Nakamura, K., Fukuhara, S., Amano, T., Yamamoto, H., Ide, Y., Suzuki, M., Teramoto, S., et al. β-defensin overexpression induces progressive muscle degeneration in mice. Am. J. Physiol. Cell Physiol. 292 (2007), C2141–C2149.
58. Yount, N.Y., Bayer, A.S., Xiong, Y.Q., Yeaman, M.R., Advances in antimicrobial peptide immunobiology. Biopolymers 84 (2006), 435–458.
59. Zhao, H., Lee, W.-H., Shen, J.-H., Li, H., Zhang, Y., Identification of novel semenogelin I-derived antimicrobial peptide from liquefied human seminal plasma. Peptides 29 (2008), 505–511.